Amgen sales rise, but shares off as investors await obesity data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Amgen (AMGN) tops profit expectations, revenue rises 5%
October 31, 2023 7:58 AM EDTAmgen (NASDAQ: AMGN) reported earnings for its latest quarter on Tuesday, topping consensus profit expectations and raising guidance.
The company reported Q3 EPS of $4.96, $0.28 better than the analyst estimate of $4.68, while revenue for the quarter came in at $6.9 billion, up 4% YoY but slightly... More
